PARP Inhibition in HRR Gene--Mutated Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 90
- By:
- Publication type:
- Article
Works matching IS 15430790 AND DT 2025 AND VI 23 AND IP 2
Results: 9
1
2
Is There a New Standard-of-Care Therapy for Advanced Hodgkin Lymphoma?
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 76
- By:
- Publication type:
- Article
3
Update on PARP Inhibitors for the Treatment of Ovarian Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 100
- By:
- Publication type:
- Article
4
A Common Cause.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 66
- By:
- Publication type:
- Article
5
Thrombosis in Immune Thrombocytopenia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 87
- By:
- Publication type:
- Article
6
Ethics in Medicine: Avoiding Conflicts of Interest in Prescribing.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 93
- By:
- Publication type:
- Article
7
The Use of Fixed-Dose Regimens in Chronic Lymphocytic Leukemia.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 84
- By:
- Publication type:
- Article
8
Management of Toxicities From Antibody-Drug Conjugates.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 96
- By:
- Publication type:
- Article
9
Targeting RAS in Gastrointestinal Malignancies.
- Published in:
- Clinical Advances in Hematology & Oncology, 2025, v. 23, n. 2, p. 111
- By:
- Publication type:
- Article